CClinicalTrials.gg
WithdrawnNCT05103514Updated Apr 6, 2026

The Longitudinal Impact of SES and the CNDS on Recovery From SUD

An observational study in Substance Use Disorders, sponsored by Virginia Polytechnic Institute and State University. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-06.

Sponsored by Virginia Polytechnic Institute and State University · Observational

Why this study was withdrawn
proposal not funded
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to provide a scientific understanding of the impact of socioeconomic status (SES) on the recovery trajectory (psychosocial functioning, relapse/remission status, and neurocognitive mechanisms).

Read the detailed description

The study will characterize the effect of SES (subjective and objective indicators) on long-term trajectories of recovery and neurocognitive functioning. By using an accelerated longitudinal design, the investigators will examine the association between baseline SES, changes in CNDS, and changes in psychosocial functioning (e.g., quality of life) and relapse. Moreover, the investigators will use computational modeling to capture underlying changes in components of CNDS functioning related to SES and SUD recovery.

02

Conditions studied

  • Substance Use Disorders
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

Browse Substance-Related Disorders studies →

Lead sponsor

Virginia Polytechnic Institute and State University is the lead sponsor of 124 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals in recovery from SUD who meets the study inclusion criteria will be recruited from The International Quit \& Recovery Registry (IQRR) (https://quitandrecovery.org). Participants will be recruited from existing or new IQRR registrants; that is, IQRR registrants meeting the inclusion criteria (see above) will be invited to participate. Also, the recruitment of new registrants will use methods designed to reflect the heterogeneity of the recovery population.

Inclusion criteria

  1. be ≥18 yrs old
  2. meet lifetime DSM-5 SUD criteria
  3. have a Recovery Initiation Date less than 3 years prior to the time of enrollment
  4. be able to read independently
  5. be free of legal problems that could limit participation
  6. reside in the U.S.
  7. anticipate continued Internet access (to ensure ongoing contact and data collection)
  8. be a registrant of the International Quit and Recovery Registry (IQRR)

Exclusion criteria

Exclusion Criteria:

  1. Minors will not be included
  2. Prisoners will not be included. If participants become incarcerated during this study, they will not be contacted to complete assessments during their incarceration. If the incarceration ends during the study, they may be contacted to participate in assessments.
  3. Adults who are not capable of consenting on their own behalf
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Cohort 1

    Participants in this group started their recovery process \< 1 year ago

    Other: Online Survey

  • Cohort 2

    Participants in this group started their recovery process 1 to \<2 years ago

    Other: Online Survey

  • Cohort 3

    Participants in this group started their recovery process 2 to \<3 years ago

    Other: Online Survey

Interventions

  • OtherOnline Survey

    There are no interventions planned for this study. This is an observational study only.

06

What researchers measure

Primary outcomes

  1. Change in Socioeconomic Status (SES)- Individual Subjective SES

    Individual Subjective SES will be determined using the MacArthur Scale of subjective social status. Participants will be presented with two social ladders that have 10 steps each and asked to place themselves on the rung that best represent where they stand at this time in their life (1=lowest rung and 10= highest rung), relative to other people in (1) the United States and (2) their community. Higher scores on the 10-rung ladder indicate higher subjective SES.

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  2. Change in Socioeconomic Status (SES)- Individual Objective SES

    Individual Objective SES will be measured using a composite that was developed by the US Department of Justice (i.e. National Crime Victimization Survey Index 1) that incorporates four main SES elements (i.e., income, education, employment status, and housing tenure measures). Specifically, the SES composite index includes two individual level characteristics: education (possible range: 0-3) and employment in the last 6 months (possible range: 0-1); and two household level characteristics: income as a percentage of the federal poverty level (FPL; possible range: 0-3) and housing tenure (possible range: 0-1). The final SES score (possible range: 0-8) is collapsed into three levels: low (total score of 0 to less than 3), middle (total score of 3 to less than 6), and upper (total score of 6-8) SES.

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  3. Change in CNDS functioning

    Delay Discounting (DD) task will be administered to assesses the value of delayed reinforcers. Participants make hypothetical choices between amounts of delayed and immediate money at various delays (e.g., 1 day to 25 years)

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  4. Change in Psychosocial Functioning- The Psychosocial Functioning Inventory (PFI)

    The Psychosocial Functioning Inventory (PFI) will be used to measure social functioning. The social behavior sub-scale will be calculated from 10 items of the PFI and included items that assess the frequency of problematic social behavior and social interactions in the past 90 days. The psychosocial functioning scale yields a score ranging from 0-100, with higher scores indicating greater impairment.

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  5. Change in Psychosocial Functioning- World Health Organization (WHO)-Quality of Life

    WHO-Quality of Life brief assessment (BREF) will be used to measure the four domains of quality of life: (1) physical health; (2) psychological (3) social relationships; and (4) environment (26 items). Each item in the WHOQOL-BREF will be scored with a 5-point Likert scale (three items are reverse scored), and these scores will be used to generate raw scores for each domain, which will be then scaled 0-100, with higher scores indicating greater quality of life.

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  6. Change in Psychosocial Functioning- Satisfaction with Life and social Functioning

    Satisfaction with life and social functioning over the past 90 days will be assessed using 4 questions: How happy have you been (1) with life?; (2) with your living situation? and (3) with your relationships? and (4) Did you feel satisfied with leisure, social, and recreational activities? (0 = satisfied/happy; 1 = dissatisfied/unhappy)

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  7. Change in Psychosocial Functioning- Career Engagement

    Engagement in proactive career behaviors over time (9 items). Each item in the career engagement measure will be scored with the 5-point Likert-type scale. The average scale scores will range between 1-5 with higher score indicating greater engagement.

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  8. Change in Psychosocial Functioning- Addiction Severity

    The Addiction Severity Index (ASI) will be used to assess experiences of serious depression, serious anxiety or tension, and cognitive difficulty (i.e., trouble understanding, concentrating, or remembering) in the past 90 days. All items will be binary indicators, where 0 = employed or symptom not present and 1 = unemployed or symptom present. Items will be examined individually.

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  9. Change in Substance Use- SUD Status and Severity

    The Diagnostic and Statistical Manual-5 (DSM-5) SUD (last year \& last 3 months) will be used to assess SUD status and severity with mild, moderate, and severe sub-classifications

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

  10. Change in Substance Use- Consumption

    Timeline Follow Back-90 (TLFB-90) will be used to obtains retrospective daily estimates of substance use in the last 3 month. TLFB can generate a variety of variables that provide more precise and varied information (e.g., pattern, variability) about a person's substance use

    Time frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05103514
Lead sponsor
Virginia Polytechnic Institute and State University
Responsible party
Jeffrey Stein (Professor, Virginia Polytechnic Institute and State University) — Principal investigator
First posted
Nov 2, 2021
Start date
Dec 1, 2025 (estimated)
Primary completion
Apr 1, 2028 (estimated)
Completion
Jul 1, 2028 (estimated)
Last update
Apr 6, 2026

Study contacts

Warren Bickel, PhD
principal investigator · Virginia Polytechnic Institute and State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion